Bioxytran, Inc. (BIXT)
OTCMKTS · Delayed Price · Currency is USD
0.0597
+0.0001 (0.24%)
At close: Jan 21, 2026
Bioxytran Employees
Bioxytran had 3 employees as of December 31, 2023. The number of employees increased by 1 or 50.00% compared to the previous year.
Employees
3
Change (1Y)
1
Growth (1Y)
50.00%
Revenue / Employee
n/a
Profits / Employee
n/a
Market Cap
6.46M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2023 | 3 | 1 | 50.00% |
| Dec 31, 2022 | 2 | 0 | - |
| Dec 31, 2021 | 2 | 0 | - |
| Dec 31, 2020 | 2 | 0 | - |
| Dec 31, 2019 | 2 | 0 | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| American Oncology Network | 1,914 |
| Glass House Brands | 374 |
| Silence Therapeutics | 116 |
| Vaxart | 105 |
| Elite Pharmaceuticals | 68 |
| Northwest Biotherapeutics | 25 |
| CytoDyn | 13 |
| OpGen | 1 |
Bioxytran News
- 2 months ago - Bioxytran Announces Initiation of Coverage of its Stock by Independent Research - GlobeNewsWire
- 3 months ago - Bioxytran Completes Randomized Clinical Trial For its Broad-Spectrum Antiviral Drug - GlobeNewsWire
- 5 months ago - Bioxytran Unveils Revolutionary Precision Diagnostics on Tissue Oxygenation - GlobeNewsWire
- 5 months ago - Bioxytran's Breakthrough Broad-Spectrum Antiviral Technology Poised to Revolutionize Respiratory Infection Treatment - GlobeNewsWire
- 7 months ago - Bioxytran Secures a Source of GMP Quality Camel Hemoglobin - GlobeNewsWire
- 8 months ago - Bioxytran's Groundbreaking Stroke & Alzheimer's Tech Gains Validation That Measures Oxygenation Uptake During Strokes - GlobeNewsWire
- 8 months ago - Bioxytran's Antiviral Breakthrough Featured in University of Georgia's $100M HPAI Poultry Innovation Grand Challenge Submission - GlobeNewsWire
- 9 months ago - Bioxytran Completes Dose Optimization of Antiviral, ProLectin-M - GlobeNewsWire